Does ALIROCUMAB Cause Myocardial infarction? 374 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 374 reports of Myocardial infarction have been filed in association with ALIROCUMAB (Praluent). This represents 1.6% of all adverse event reports for ALIROCUMAB.
374
Reports of Myocardial infarction with ALIROCUMAB
1.6%
of all ALIROCUMAB reports
27
Deaths
215
Hospitalizations
How Dangerous Is Myocardial infarction From ALIROCUMAB?
Of the 374 reports, 27 (7.2%) resulted in death, 215 (57.5%) required hospitalization, and 18 (4.8%) were considered life-threatening.
Is Myocardial infarction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALIROCUMAB. However, 374 reports have been filed with the FAERS database.
What Other Side Effects Does ALIROCUMAB Cause?
Myalgia (1,571)
Product dose omission (1,354)
Injection site pain (1,220)
Muscle spasms (1,113)
Arthralgia (993)
Fatigue (922)
Pain (892)
Pain in extremity (888)
Product dose omission issue (864)
Injection site bruising (821)
What Other Drugs Cause Myocardial infarction?
ROSIGLITAZONE (17,018)
TESTOSTERONE (3,396)
ADALIMUMAB (3,214)
SACUBITRIL\VALSARTAN (3,120)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,391)
APIXABAN (2,010)
TICAGRELOR (1,749)
LENALIDOMIDE (1,712)
ETANERCEPT (1,693)
METFORMIN\ROSIGLITAZONE (1,640)
Which ALIROCUMAB Alternatives Have Lower Myocardial infarction Risk?
ALIROCUMAB vs ALISKIREN
ALIROCUMAB vs ALISKIREN HEMIFUMARATE
ALIROCUMAB vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALIROCUMAB vs ALIZAPRIDE
ALIROCUMAB vs ALLANTOIN